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 Psoriasis is a hyper proliferative, autoimmune skin disorder. Despite the fact that many 
therapies are there in treating psoriasis, no single treatment gives complete and satisfactory 
cure. There are several therapeutic agents used topically and systemically but they have 
adverse effects. As an alternative for these drugs, herbal medicine have been widely used. 
These have better therapeutic value and have less side effects.  Nano herbal drug delivery 
systems have a great future for increasing the activity and succeeding in dealing with the 
problems related with medicinal plants. Various marketed herbal formulations are available. 
Please cite this article in press as Padmini Iriventi et al. Nanotechnology in Management of Psoriasis: A Focus on Herbal 
Therapy. Indo American Journal of Pharmaceutical Research.2017:7(01). 
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INTRODUCTION: [1]
 
Psoriasis is a skin disease which is distinguished by massive proliferation, thick inflammatory cell infiltrates, generation of 
new blood vessels, modifications in lymphatic structure and impaired differentiation of epidermis .It is an autoimmune disorder where 
environment and genetic components have a major function. 
 
Historical perspective and epidemiological studies: [1, 2] 
Psoriasis is an inflammatory disease which has been existing from ancient times and is cosmopolitan. It was initially 
described in the Corpus Hippocraticum. The term psora was used by Hippocrates (460-377 BC), that means, 'to itch'. In simple terms 
Psoriasis is a non communicable regular skin disorder that leads to instant skin cell reproduction leading  in red, dry patches of 
thickened skin. The dry flakes and skin scales are the result of the instant and sudden formation of skin cells. Psoriasis commonly 
affects the skin of the elbows, knees, and scalp. Skin sores can not only be itchy and defaced, in 10-30% of patients there can also be 
nail dystrophy associated with psoriatic arthritis. The swelling in the joints is alike in few forms to Rheumatic arthritis (RA), although 
in psoriasis it is a seronegative arthritis (no rheumatoid factor is present in the blood). Thus the various clinical evidences of psoriasis 
make it more than a skin disorder, as it hampers certain usual daily actions, like using hands, sleeping, walking etc. The Crohn disease 
which is an inflammatory bowel disorder, is one of the most serious problem related with psoriasis other than arthritis. 
Both the sex are equally affected by this disorder and is seen at all ages, especially first time between the ages 15-25 years. It 
is a lifelong inflammatory disease. 
 
Pathophysiology of Psoriasis: 
Very rapid multiplication of keratinocytes occur in people having psoriasis and their movement  from the stratum basale 
(basal layer) to the upper layer of epidermis occurs in 4 days. Thick dry patches or plaques form, as the skin does not shed the cells 
quickly[3]. In some people very mild psoriasis exists which cannot be even suspected as a skin disorder. Others have very severe 
psoriasis where almost whole body is covered with scaly, thick and red skin. Despite the fact that psoriasis occurs in population of all 
age groups, i.e., paediatrics to geriatrics, generally it is diagnosed in adolescence of a person. 
The other causative factors for psoriasis are genetics, sudden changes in genes (mutations), climate, mental or emotional strain, 
contagion, and wounds [4, 5].  
The major pathological phennomenon associated with psoriasis are
 
[6] 
1. T cell activation 
2. Activated T cells migration into the skin 
3. Reactivation of T cells in dermis and epidermis 
 
Types of psoriasis: 
Plaque psoriasis: [6, 7] 
It is also known as psoriasis vulgaris, which generally occurs (almost 80-85%). It is usually seen on elbows, knees, scalp and lower 
back. Symptoms include, 
 Spherical lesions which ranges about 0.99 cm to several cms in width, and may further grow into patches.  
 Red colored lesions which are encrusted with silvery, loose and shining skin.  
 Lesions that are generally seen on the elbows, knees, and trunk.  
Causes due to which this type occurs are generally infections, skin abrasion, medications, sunlight, strain, smoking and drinking. 
 
 
 
Fig 1: Plaque psoriasis [8] 
 
Guttate psoriasis: [6] 
It is also known as rain drop psoriasis and is the second general form (around10%) seen in population with psoriasis.Symptoms are 
 Several minute rain drops sized lesions  
 Lesions grow instantly, generally on the trunk, arms, legs, and scalp 
 Eruption of lesions which may occur along with any upper respiratory infection.  
Causes are streptococcal infection, viral or bacterial contagions, skin wounds and burns, insect bites etc, sunlight, medicine etc. 
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Fig 2: Guttate psoriasis [8]. 
 
Psoriatic arthritis: [6, 9] 
It is a condition in which swelling occurs which shows impact on the joints. Generally appears in 6% to 40% of population 
having this skin disorder. 
Symptoms of psoriatic arthritis include: 
 Inflated, sore, thick, and painful joints,  
 Above signs may be seen earlier, along with, or following the development of symptoms of the skin.  
 In the hands and feet, joint symptoms are seen. 
Causes are shock or wounds on skin, medications, agents that cause irritation of skin, smoking and drinking etc 
 
 
 
Fig 3: Psoriatic arthritis [8]. 
 
Pustular psoriasis: [6] 
It can occur as patches which are small or wide spread on areas of feet, hands or fingertips. Seen in 5% or less population 
having  psoriasis. Symptoms are, 
 Fluid-filled lesions which are seen on soles and palms. Very scaly skin.  
 Alterations in nail.  
 Eruptions which are seen after discontinuation of certain medications and creams. 
Causes are pregnancy, overexposure to UV light, systemic steroids, contagions, mental and    emotional strain, and sudden with 
drawal of certain medications. 
 
 
 
Fig 4: Pustular psoriasis [8]. 
 
Erythroderma, or exfoliative psoriasis: [6] 
It is a very uncommon type that may be damaging or lethal. In population with this type, along with skin, symptoms are seen 
on whole body like 
 Inflation and soreness which occurs on entire body skin. The skin may slough off and is generally itchy and tender.  
 Incapable to monitor temperature of the body and chills.  
Causes are use of steroid, extreme sun burn, strain, drinking alcohol, contagions, sensitivity etc. 
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Fig 5: Erythroderma [8]. 
Nail psoriasis: [6] 
Along with building up of skin cells under epidermis, in half of the psoriasis population they even develop under nails, which 
becomes impenetrable. They mostly split and in extreme cases, they fall down or collapse. Yellow or brownish red spots are seen 
below the nail.  
Causes of this type is not known exactly, but generally it is considered having a genetic factor.
 
[10] 
 
 
 
Fig 6: Nail psoriasis [8]. 
Genetic factors 
Human genome scans show almost nine various loci which are susceptable to psoriasis (PSORS1-9).PSORS-1, is the main 
genetic factor of this disorder, which results up to 50% of genetic sensitivity to psoriasis. The risk of psoriasis may be increased due to 
certain variations and changes, which are related with four auto immune diseases: type 1diabetes, Celiac disease, Grave’s disease and 
rheumatoid arthritis describing that all above disorders have the same genetic factors.
 
[11] 
 
Trigger Factors 
Climate, strain, wounds, medicines are indirect causes and infections like HIV, one of the uncommon forms of Human 
Papiloma viruses (HPV) like EV-HPV, Streptococcal infections in upper respiratory tract lie sinusitis, tonsillitis are mostly important 
in triggering the disease process that commences and intenses psoriasis. [12] 
 
Diagnosis: 
Based on clinical studies such as skin rash, alterations in nails, joint involvement etc psoriasis is diagonised. Occasionally 
patients show uncommon skin sores that have to be distinguished from  mycosis fungicides, seborrhoiec dermatitis, tinea, discoid 
lupus or undesignated skin syptoms like very little scaling of the scalp, isolated flexural erythema, or genital lesions. Thorough 
inspection of the body sites must be done to reveal unrecognised, clinically useful characteristics, and occasionally a skin biopsy may 
be required. Fusions of the various types may develop occasionally along with or later in the same patient. The silvery white scales, 
which are filled with dark pink or red lesions having prominent edges can be separated easily for diagnosis of psoriasis. After scraping 
off the moist skin, tiny blood droplets appear under the scales which are seen under pinkish moist tender skin. Scraping or skin biopsy 
and blood analysis may be necessary sometimes, to approve the diagnosis. [4] 
 
Severity of disease: [13]
 
The extremity of this disease occurs from one or two small flaky swollen patches to extensive pustular psoriasis which in 
atypical cases can be lethal. To help in determining the suitable treatment for a patient, physicians generally classify psoriasis as mild 
to severe which is usually done based on percentage of skin impacted. 
 Mild: Affected body area is ˂ 3% affected. Less than 2% of the skin is affected in most cases of psoriasis. 
 Moderate:  3-10% skin is impacted. 
 Severe:  ˃10% of the body is influenced. 
Treating severe psoriasis is harder. However, though not categorized under severe psoriasis, few types of psoriasis are 
unaffected to treatment which include, 
 Hand and Foot psoriasis (Any psoriasis that occur on palms and soles) 
 Psoriasis that is seen in the fold of the skin (Inverse) 
 Psoriatic arthritis 
 Scalp psoriasis 
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Therapies to treat psoriasis:             
There are various therapies for treating psoriasis. Any therapy should be considered on long term basis. General therapies 
present for treating psoriasis are systemic agents (medicines within the body), topical agents (medicines applied to the skin) and 
phototherapy. All these treatments may be used single or in combination with one another. Best treatment for the individual is 
determined by the physician situated on the kind and extremity of psoriasis.  
Various approaches are: 
 
Topical Therapy:  
 These are the medications that are directly applied on the skin and are the first line of therapy options. Topical creams, sprays 
and lotions are very effective for mild psoriasis and is also safe to use. Corticosteroids, vitamin D-3 derivatives [14], retinoids, coal tar 
or anthralin [15]
 
are the main topical treatments. Combination of these preparations can be given sometimes. For example, keratolytics 
are often added to topical preparations.  
 Because of interference with each other some preparations should never be mixed together. For example,when  salicylic acid is added 
to calcipotriene cream or ointment (a form of vitamin D-3) it inactivates the substance, while salicylic acid is required to be to 
medicines like anthralin to work effectively. 
 
Photo therapy: [13] 
 Skin would be exposed to ultraviolet (UV) radiation in case of failure of topical treatments in achieving desired goal. This 
type of treatment is called phototherapy. This therapy includes subjection to UV radiations with the help of special apparatus utilizing 
fluorescent light source discharging specific wavelength of radiation. Psoriasis responds to ultraviolet rays. Symptoms get reduced on 
frequent subjection to sun or artificial ultraviolet rays. Methods are: 
 Subjection to ultraviolet B light,i.e., UVB(290-320nm) 
 Subjection to UV rays (320-400nm) combined with the drug psoralen,i.e.,PUVA, which expands the skin’s light sensitivity.  
   There are other new methods like lasers, that emphasize the useful results of light particularly on psoriatic sores. UV light 
therapy is the basic treatment with ultimate outcomes for treating psoriasis. 
 
Systemic Therapy: 
 Systemic Therapy is majorly used in moderate to severe cases or when no response for,topical treatment and photo therapy is 
seen 
[6]
. Those patients who undergo systemic treatment must have frequent blood and liver function tests since the medicines used are 
toxic [13].  Generally three main drugs are used in systemic treatment. 
 
Methotrexate: 
 This is a popular anti-metabolite which is very effective agent used in treating severe psoriasis [13]. Irrespective of its 
benefits it has limitations as it is related with extreme acute and chronic adverse reactions that involve acute hematologic toxicity and 
acute and chronic hepatotoxicity. This treatment should be restricted to patients with disabling, refractory psoriasis. [17]  
 
Cyclosporine: 
It is a cyclic polypeptide and mostly used in organ transplantation as an immunosuppressant. It shows inhibitory effects on T-
cells and acts on psoriasis. Cyclosporine should be limited for patients with severe psoriasis. Major side effects associated with this 
drug are nephrotoxocity and hypertension. Risk of malignancies may be increased. [13] 
 
Acitretin: 
   Actretin is an oral retinoid which act by its anti-inflammatory action. It shows good effect on combining with topical agents 
or light therapy in the generalized pustular and erythrodermic types of psoriasis [5]
 
Though this drug has related teratogenic risk which 
exists for two to three years after terminating therapy it is the safest systemic treatment for psoriasis. [13] 
 
Treatment using Biologics: 
Biologics are means that inhibit molecular steps vital in the pathogenesis of this disease. They have grown in past few years 
as a good substitute therapeutic choices in treating psoriasis. They are of 2 types: agents that target the cytokine tumour necrosis factor 
α (example, adalimumab, etanercept) and agents that target T cells or antigen presenting cells (example, efalizumab). Though they 
have to be administered parentally, they are widely accepted by patients due to dissatisfaction with other treatments [18] and have led 
to high demand. 
 
Combination Therapy  
Combining various therapies like topical, photo, and systemic often results in reduction of doses of each therapy and can 
result in increased effectiveness. Therefore, physicians are focusing more on combination therapy. [27] 
 
Herbal Therapy: 
 Plants and its constituents are used in herbal therapy which has less side effects than synthetic drugs. These days, herbal 
resources play an important role in the management of the skin and inflammatory diseases. [13] 
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Advantages: 
 Increases therapeutic value by reducing toxicity and side effects 
 Easily available 
 More effectiveness 
 
Disadvantages: 
 High cost 
 Difficulty in scaling up 
 Have toxicity and stability issues 
There are many herbal drugs which show anti psoriatic effect. 
 
Wrightia tinctoria: 
 
 It is commonly known as Dyer’s oleander, Indrajau and belongs to the family Apocynaceae. Leaves has astringent, anti 
inflammatory and anti bacterial properties and is used in treating various skin disorders [19]. From leaves of this plant a hydro 
alcoholic extract was obtained which shows antipsoriatic effect. This extract has a good antioxidant activity. These leaves contain beta 
amyrin and glucoside, which are reasonable for the skin healing properties of plant. [22] 
 
Silybum marianum: 
 
 Its common name is Milk Thistle and belongs to the family Asteraceae.  Liver neutralizes certain toxins associated with 
psoriasis. This herb increases liver function and prevents outbreak of psoriasis. It may prevent human T-cell activation that is normally 
seen  in this disorder[13].  Active ingredient which protects liver is Silymarin, a chemical constituent extracted from the seeds. 
Silymarin consists of a group of flavonoids (Silibinin, Silidianin and Silicristin) that repairs hepatic cells
 
[23]. 
 
Aloe vera: 
 
 It belongs to the family Asphodelaceae. The gel and the rind of the aloe vera leaf contains pharmacologically active 
components like anthraquinone and acemannan which have properties like analgesic , anti inflammatory, anti pruritic, wound healing 
etc. and hence can be used in treating psoriasis [13, 19]. 
 Aloe vera moisturizes skin by forming a protective layer which prevents bacterial growth. Saliclic acid is a proven antiseptic agent 
used in psoriasis treatment which is present in Aloe vera 
 
[24, 25]. 
Work done on aloe vera states that 0.5% Aloe vera extract in a hydrophilic cream was well tolerated and found to be very effective 
[26]. 
 
Angelica sinensis:
 
[19] 
 It is commonly known as Dong quay and belongs to the family Apiaceae. Extracts of this herb contains furocoumarin,i.e, 
Psoralen which acts as a potent photosensitizer in existance of ultraviolet A. Exposure to UVA along with Psoralen consumption leads 
to cross linking of epidermal DNA  which reduces epidermal DNA synthesis rate. 
 
Capsicum annuum: 
 
 It is commonly known as Cayenne and belongs to the family Solanaceae. Major component is capsaicin. Substance- P (SP) 
mediates a neurogenic inflammatory condition which occurs in psoriasis [19]. 
Capsaicin decreases  neurotransmitters from the sensory nerves and thus reduces  pain and itching associated with psoriasis [27]. 
 
Smilax china:
 
 It is commonly known as China root, which belongs to the family Smilacaceae. Rhizome part of the plant is used and this 
contains flavonoid quercitin which can be isolated from the methanolic extract. This flavonoid shows antipsoriatic activity by reducing 
epidermal thickness, which is due to reduction of leucocyte migration [19, 20, 28]. 
 
Ulmus rubra: 
 
[20] 
 It is commonly known as slippery elm and belongs to the family Ulmaceae. It contains a mucilage component which is 
derived from the inner bark of the elm. 
 
Mahonia aquifolium: 
 
 It belongs the family Berberidaceae and is commonly called as Oregon grape. Bark extract of this drug is used which 
consists of berberine, berbamine, oxycanthine as major constituents. It inhibits keratinocytes growth
 
[19, 21]. 
Alkaloids like berberin, protoberberine, berbamine and oxycanthine that are present in the root and bark extract of this plant have very 
good antimicrobial and antifungal activity. These alkaloids arrest the proliferation of various tumour cells as well as incorporate 
powerful antioxidant activity which hinders keratinocytes and reduces inflammation. [29] 
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Nigella sativa:  
 It is commonly known as black cumin and belongs to the family Ranunculaceae . 95% of ethanol extract of seeds of this 
herb shows significant epidermal differentiation and reduces epidermal thickness [19]. 
A study conducted on seed extract of this plant on an animal model of psoriasis, in which the histological  effects were examined has 
shown that Nigella sativa has anti-psoriatic activity [30]. 
 
Thespesia populnea: 
 It is commonly known as ortia tree and belongs to the family Malvaceae. It has been traditionally used in treatment of 
psoriasis along with other skin disorders like ring worm, eczema, scabies etc. Oil which is obtained by boiling the bark in coconut oil 
is applied externally in scabies psoriasis [31]. 
 In one study the screening for anti psoriatic activity was carried out by topically applying various extracts and isolated 
compounds like TpF-1, TpF-2 and TpS-2 [32]. 
 Apart from the above mentioned drugs many other herbal drugs are used in treatment of psoriasis like Matricaria recutita, 
Curcuma longa, Alpinia galangal, Indigo naturalis, Gaultheria procumbens, Cassia tora, Momordica charantia etc. 
All these drugs show significant anti psoriatic effect by following different mechanism pathways. 
 
Nutritional Therapy: 
 To reduce severity of psoriasis, more water should be consumed. Lots of green leafy vegetables should be taken which will 
reduce the intensity of this condition [13]
 
. Few foods trigger the disease and they should be avoided. Eg: Coke, Vit-C,junk food, oily 
food, red meat, acidic food etc. Psoriasis worsens in those people who follow poor diet.
 
Consumption of alcohol is proved to be a 
probability component for this disorder in men. Avoiding gluten (found in wheat, barley) is also good. Fumaric acid, fish oil, 
triglcerides, Vit-D, folic acid are found to be effective against psoriasis [33, 34]. 
 
Hydro therapy: [27] 
 Hydro or Water therapy is used as alternative therapy for psoriasis in which the skin is supplied with moisture, heat and 
certain minerals.  The use of warm water for bathing improves  blood circulation.Water rich in sulphur and other minerals should be 
used for bathing  which will tend the skin.  
To prove water therapy works in treating psoriasis, the sufferers were made to bathe in the Dead sea which is rich in salt and minerals 
and due to presence of ultraviolet light radiation the location was perfect for sunbathing. 
 
Role of Nanotechnology in treating Psoriasis: 
  Nano particles are the colloidal systems with particle size varying from 10 nm to 1000nm. These are nano or sub nano sized 
structures which are made of synthetic or semi synthetic polymers. Nanoparticles of plant medicine is gaining a lot of attention 
currently [35]. 
  Herbal drug delivery has certain problems due to poor solubility, low bioavailability, instability in biological medium and 
high first pass metabolism and poor permeability. Nanotechnology is useful to overcome all these problems [36, 37]. 
Merits of plant nanoparticle delivery system: [38, 39] 
 Delivery of formulation to the targeted site 
 Drug solubility and Pharmacokinetics can be improved by encapsulating the drugs within nanoparticles 
 Bioavailability of drugs can be increased 
 Degradation of drugs can be avoided 
 Delivering the drug in small particle size increases the surface area of the drugs which allocates quicker dissolution in the blood 
 Decreases side effects 
 Decreases the dose of the formulation 
 
Approaches of NanoTechnology: 
 Polymeris nanoparticles, Solid lipid nanoparticles, Liposomes, Proliposomes, Niosomes, Liquid crystalline systems, 
Quantum dots etc are the various approaches of nanotechnology. 
 
Herbal constituents : 
Various constituents that possess anti psoriatic activity are isolated from many herbal plants. 
 Artesunate is an active constituent which is derivative of Artemisinin that is processed from plant Artemisia annua L. of family 
Asteraceae. It acts by controling the expression of CXCR2 and increases the secretion of TGFβ, in vitro [40]. 
 Capsaicin is derived from Capsicum annuum of family Solanaceae [41]. 
 Colchicine,  an active constituent Colchicum autumnale of family Colchicaceae [42]. 
 Curcumin is derived from Curcumin longa belonging to the family Zingiberaceae shows its activity as selective phosphorylse 
kinase inhibitor, thereby decreasing  inflammation through inhibition of NFKB [43]. 
 Psoralen, is derived from Psoralea corylifolia of family Fabaceae. It inhibits epidermal DNA synthesis and thereby cell division 
[44]. 
 Koumine is derived from plant Gelsemium elegans belonging to the family Loganiaceae. It acts by inhibiting epidermal cell 
proliferation, promoting formation of granular cells, decreasing serum IL-2 levels [45]. 
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Some other constituents derived from various plants are Iso-Camptothecin Hypericin, Podophyllotoxin, Isoquinoline etc [46, 47, 48, 
49]. 
 
Herbal anti psoriatic formulations: 
Several anti psoriatic herbal formulations are available and few of them are listed in Table 1. 
 
Table 1: Anti psoriatic Herbal formulations. 
 
Formulation Mode of action 
Ginkgo and megranate (Chinese in vitro medicine) 
 
Downregulates the expression of VEGF 
and PlGF [50] 
Composite Shendi decoction (CSDD) and Diyin tablet (DYT) (Chinese 
formulation) 
Serum IL-8 and plasma endothelin 
level reduced [51] 
Chunghyuldan (Scutellariae Radix, Coptidis Rhizoma, Phellodendri 
Cortex, Gardeniae 
Fructus, Rhei Rhizoma) (Chinese formulation) 
Regulation of COX-II produced by 
macrophage cells, and IFN-γ and IL-4 
produced by T cells [52] 
Lixue xiaoyin decoction (Chinese formulation) Improves microcirculation and inhibits 
division of epidermal cells [53] 
Qingdai compound capsule (Chinese formulation) Decrease in expression of c-myc in keratinocytes [54] 
Quyin granule (Chinese formulation) Inhibition of faster epidermal cell proliferation and 
improvement of 
parakeratotic epidermal cells [55] 
Radix Sophorae Flavescentis (Sophora flavescens Ait.) Inhibition of hyperplasia of epidermis 
cells and the promotion to the formation 
of granular layer [56] 
 
Other herbal formulations which are used in treating psoriasis are Yinxie capsules, Tuhuai extract, Relieva, Vitamin B12 
cream containing Avocado oil etc [57, 58, 59, 60 ]. 
 
Patents on antipsoriatic herbal products: 
List of patents on anti psoriatic herbal products are given in table 2.  
 
Table 2: Patents on anti psoriatic herbal formulations. 
 
Composition Formulation 
Carthami tinctorii Flores, Guaiacum officinale, Pardanthi dichotomy Radices, 
Parmeliae herba of moss, Pyrus baecate 
Chinese medicinal composition 
 
[61] 
Herba Chelidonii (Chelidonium majus) Topical emulsion or ointment [62] 
Et Hg thiosalicylate, plantain extract, rose extract, orange extract Topical composition [63] 
Arnica Herb, marigold, Fructus Rhodomyrti, Radix Hamamelis Mollis, 
Avocado 
Medicinal ointment [64] 
Turmeric extract, α-hydroxy acids,α1-antitrypsin Topical formulation [65] 
Moisturizing cream, berberine, oleuropein, glucosamine Cream [66] 
Mussel, Carnis Rapanae Thomasianae, Concha Ostreae, Concha Meretricis Seu 
Cyclinae, Liushugu, Scolopendra 
Topical or oral composition [67] 
Psorberine (M. aquifolium alcohol-water extract) Topical formulation [68] 
Mimosine and idebenone 
Occlusive patch, cream, gel, emulsion, 
spray [69] 
Wrightia tinctoria oil extract 
Hydrophobic topical formulation (cream, 
ointment) [70] 
 
Other than those listed in above table, many more patents are present which are claimed on antipsoriatic herbal formulations. 
 
Future scope: 
 Use of herbal drugs in treatment of psoriasis is gaining importance gradually. So, dosage forms which can overcome the 
present existing disadvantages of herbal formulations can be prepared. Among them nanoparticles occupy the first place. Researchers 
and scientists are currently working to develop nanoparticulate drug delivery systems that can treat psoriasis with minimal side effects. 
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